Mucinous cystadenocarcinoma laboratory findings

Jump to navigation Jump to search

Mucinous cystadenocarcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Mucinous Cystadenocarcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucinous cystadenocarcinoma laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mucinous cystadenocarcinoma laboratory findings

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucinous cystadenocarcinoma laboratory findings

CDC on Mucinous cystadenocarcinoma laboratory findings

Mucinous cystadenocarcinoma laboratory findings in the news

Blogs on Mucinous cystadenocarcinoma laboratory findings

Directions to Hospitals Treating Mucinous cystadenocarcinoma

Risk calculators and risk factors for Mucinous cystadenocarcinoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Blood workup of patients suffering from mucinous cystadenocarcinoma may reveal positivity for various tumor markers such as CA-125, elevated human chorionic gonadotropin (HCG), alpha-fetoprotein, lactate dehydrogenase, inhibin, estrogen and testosterone levels.

Laboratory Findings

Blood workup of patients suffering from mucinous cystadenocarcinoma may reveal positivity for the following tumor markers:

References

Template:WH Template:WS